These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15182102)

  • 21. Newer uses of NSAIDS.
    McCaffery M
    PRN Forum; 1985; 4(4):1-3, 6. PubMed ID: 3161113
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of non-arterial ischemic anterior optic neuropathy. Clinical study].
    Costin D; Popa DS; Broşteanu M; Darabă O
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):613-6. PubMed ID: 15832985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pain managements in the elderly].
    Hiraishi T; Hanaoka K
    Nihon Ronen Igakkai Zasshi; 1999 Nov; 36(11):769-75. PubMed ID: 10655732
    [No Abstract]   [Full Text] [Related]  

  • 24. Dopaminergic therapy with carbidopa L-dopa for left neglect after stroke: a case series.
    Mukand JA; Guilmette TJ; Allen DG; Brown LK; Brown SL; Tober KL; Vandyck WR
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1279-82. PubMed ID: 11552204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [L-dopa, dopamine agonists, opiates... what calms down restless legs].
    Wepner U
    MMW Fortschr Med; 2005 Feb; 147(8):6, 8. PubMed ID: 18437857
    [No Abstract]   [Full Text] [Related]  

  • 26. Late onset dopa-responsive dystonia with tremor, gait freezing and behavioural disturbance and a normal dopamine transporter scan.
    Harper A; Bayliss M; Saha R; Scutt A; Nisbet A
    Age Ageing; 2008 Nov; 37(6):719-20. PubMed ID: 18922834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Descriptive study of a serie of patients affected by progressive supranuclear palsy].
    Villanueva-Haba VE; Garcés M; de Vera A; Valero C; Burguera JA
    Rev Neurol; 2001 Jun 1-15; 32(11):1027-30. PubMed ID: 11562823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excitability of the lower-limb area of the motor cortex in Parkinson's disease.
    Vacherot F; Attarian S; Eusebio A; Azulay JP
    Neurophysiol Clin; 2010 Aug; 40(4):201-8. PubMed ID: 20674816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Atypical corticobasal degeneration with clinical pictures of Parkinson's disease--an L-dopa-effective case].
    Kagamihara Y
    Brain Nerve; 2007 Jun; 59(6):637-45. PubMed ID: 17585597
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current approaches in the treatment of Parkinson disease].
    Caraceni T; Geminiani G; Tamma F
    Recenti Prog Med; 1989 Dec; 80(12):686-91. PubMed ID: 2576471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopa-responsive dystonic camptocormia.
    Van Gerpen JA
    Neurology; 2006 Jun; 66(11):1779. PubMed ID: 16769967
    [No Abstract]   [Full Text] [Related]  

  • 32. Patient with limb girdle dystrophy presenting with dopa-responsive dystonia--a case report.
    Verma R; Misra S; Singh NN; Kishore D
    Neurol India; 2003 Jun; 51(2):252-3. PubMed ID: 14571018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dopa-responsive dystonia of childhood].
    Rasmussen MB; Holsteen V
    Ugeskr Laeger; 1999 Mar; 161(9):1273-4. PubMed ID: 10083825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular biology examinations of dopa-responsive dystonia].
    Romstad A; Güttler F
    Ugeskr Laeger; 1999 May; 161(20):2960. PubMed ID: 10354785
    [No Abstract]   [Full Text] [Related]  

  • 35. Dopamine agonists used as monotherapy in de novo PD patients: comparisons with selegiline.
    Lieberman A
    Neurology; 1992 Apr; 42(4 Suppl 4):37-40; discussion 41-8. PubMed ID: 1350073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinociceptive mechanism of L-DOPA.
    Shimizu T; Iwata S; Morioka H; Masuyama T; Fukuda T; Nomoto M
    Pain; 2004 Jul; 110(1-2):246-9. PubMed ID: 15275774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of levodopa on apraxia of lid opening: A case report.
    Yamada S; Matsuo K; Hirayama M; Sobue G
    Neurology; 2004 Mar; 62(5):830-1. PubMed ID: 15007147
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute exacerbation of Parkinson's disease with sulindac.
    Sandyk R; Gillman MA
    Ann Neurol; 1985 Jan; 17(1):104-5. PubMed ID: 3157343
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antiparkinsonian drugs].
    Rascol A; Montastruc JL; Rascol O
    Rev Prat; 1989 Mar; 39(8):663-9. PubMed ID: 2567051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital DOPA-responsive disorders: a diagnostic and therapeutic challenge to the cerebral palsies?
    Neville B
    Dev Med Child Neurol; 2007 Feb; 49(2):85. PubMed ID: 17253992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.